D036382Chemicals & DrugsD12.644.276.500.100D12.776.467.500.100D12.776.543.287.100D23.529.500.1004110.984072Ephrin-A1prns:fullNamefull nameprns:hasAuthorListauthor listprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:meshTreeNumberMeSH tree numberprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierDepartmentvivo:hrJobTitleHR job titleInformation ResourcePositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlevivo:researchAreaOfresearch area ofvivo:subjectAreaForsubject area forrdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPersonBiochemistryCancer BiologyWake Forest School of MedicineWaldemarDebinskiWaldemar Debinski MD, PhD36.08959100000000-80.26859900000000201Debinski, WaldemarProfessorGlennLesserGlenn J. Lesser MD36.08919100000000-80.26677800000000315Lesser, GlennProfessorMarkLivelyMark O. Lively PhD36.08919100000000-80.26677800000000654Lively, MarkProfessor EmeritusWilliamLowtherWilliam T. Lowther PhD36.08919100000000-80.26677800000000982Lowther, WilliamProfessor28746857Ivey JW, Latouche EL, Richards ML, Lesser GJ, Debinski W, Davalos RV, Verbridge SSBiophysical journalIvey JW, Latouche EL, Richards ML, Lesser GJ, Debinski W, Davalos RV, Verbridge SS. Enhancing Irreversible Electroporation by Manipulating Cellular Biophysics with a Molecular Adjuvant. Biophys J. 2017 Jul 25; 113(2):472-480.Biophys J2017-07-25T00:00:002017Enhancing Irreversible Electroporation by Manipulating Cellular Biophysics with a Molecular Adjuvant.Internal Medicine, Hematology & Oncologytrue1ProfessorProfessortrue1Professor EmeritusProfessor Emeritustrue1ProfessorProfessortrue1ProfessorProfessor22040911Beauchamp A, Debinski WSeminars in cell & developmental biologyBeauchamp A, Debinski W. Ephs and ephrins in cancer: ephrin-A1 signalling. Semin Cell Dev Biol. 2012 Feb; 23(1):109-15.Semin Cell Dev Biol2011-10-25T00:00:002011Ephs and ephrins in cancer: ephrin-A1 signalling.22362770Lema Tomé CM, Palma E, Ferluga S, Lowther WT, Hantgan R, Wykosky J, Debinski WThe Journal of biological chemistryLema Tomé CM, Palma E, Ferluga S, Lowther WT, Hantgan R, Wykosky J, Debinski W. Structural and functional characterization of monomeric EphrinA1 binding site to EphA2 receptor. J Biol Chem. 2012 Apr 20; 287(17):14012-22.J Biol Chem2012-02-23T00:00:002012Structural and functional characterization of monomeric EphrinA1 binding site to EphA2 receptor.22688511Beauchamp A, Lively MO, Mintz A, Gibo D, Wykosky J, Debinski WMolecular and cellular biologyBeauchamp A, Lively MO, Mintz A, Gibo D, Wykosky J, Debinski W. EphrinA1 is released in three forms from cancer cells by matrix metalloproteases. Mol Cell Biol. 2012 Aug; 32(16):3253-64.Mol Cell Biol2012-06-11T00:00:002012EphrinA1 is released in three forms from cancer cells by matrix metalloproteases.23661698Ferluga S, Hantgan R, Goldgur Y, Himanen JP, Nikolov DB, Debinski WThe Journal of biological chemistryFerluga S, Hantgan R, Goldgur Y, Himanen JP, Nikolov DB, Debinski W. Biological and structural characterization of glycosylation on ephrin-A1, a preferred ligand for EphA2 receptor tyrosine kinase. J Biol Chem. 2013 Jun 21; 288(25):18448-57.J Biol Chem2013-05-09T00:00:002013Biological and structural characterization of glycosylation on ephrin-A1, a preferred ligand for EphA2 receptor tyrosine kinase.2.839560.1069644research area of0.6329560.2790898subject area for